- Home
- LUNR vs NEO Comparison
LUNR vs NEO Comparison
Compare LUNR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNR
- NEO
- Stock Information
- Founded
- LUNR 2013
- NEO 2001
- Country
- LUNR United States
- NEO United States
- Employees
- LUNR N/A
- NEO N/A
- Industry
- LUNR Industrial Machinery/Components
- NEO Precision Instruments
- Sector
- LUNR Industrials
- NEO Health Care
- Exchange
- LUNR Nasdaq
- NEO Nasdaq
- Market Cap
- LUNR 1.7B
- NEO 1.9B
- IPO Year
- LUNR N/A
- NEO 1999
- Fundamental
- Price
- LUNR $18.08
- NEO $11.10
- Analyst Decision
- LUNR Strong Buy
- NEO Strong Buy
- Analyst Count
- LUNR 6
- NEO 10
- Target Price
- LUNR $15.83
- NEO $20.00
- AVG Volume (30 Days)
- LUNR 12.7M
- NEO 1.1M
- Earning Date
- LUNR 03-20-2025
- NEO 02-18-2025
- Dividend Yield
- LUNR N/A
- NEO N/A
- EPS Growth
- LUNR N/A
- NEO N/A
- EPS
- LUNR N/A
- NEO N/A
- Revenue
- LUNR $203,899,000.00
- NEO $660,566,000.00
- Revenue This Year
- LUNR $193.65
- NEO $13.00
- Revenue Next Year
- LUNR $57.06
- NEO $10.74
- P/E Ratio
- LUNR N/A
- NEO N/A
- Revenue Growth
- LUNR 134.51
- NEO 11.65
- 52 Week Low
- LUNR $3.15
- NEO $10.69
- 52 Week High
- LUNR $24.95
- NEO $19.11
- Technical
- Relative Strength Index (RSI)
- LUNR 44.35
- NEO 29.20
- Support Level
- LUNR $18.44
- NEO $10.69
- Resistance Level
- LUNR $22.40
- NEO $14.73
- Average True Range (ATR)
- LUNR 1.86
- NEO 0.81
- MACD
- LUNR -0.31
- NEO -0.19
- Stochastic Oscillator
- LUNR 10.46
- NEO 10.15
About LUNR Intuitive Machines Inc.
Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.